Should I buy Accenture (ACN) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 74% of its targets hit on this sector (207 calls tested). It aims for $220 (+3.0 %), call made on October 3, 2026, maturing on October 3, 2027 (11 d ago).
Firm-by-firm track record on Accenture
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Susquehanna | 86 % | +19.7 % | 7 | $210 -2% |
| Citigroup | 67 % | +15.4 % | 30 | $190 -11% |
| Morgan Stanley | 61 % | +14.3 % | 31 | $195 -9% |
| Deutsche Bank | 78 % | +13.0 % | 18 | $175 -18% |
| Stifel | 67 % | +10.0 % | 27 | $270 +26% |
| RBC Capital | 67 % | +8.8 % | 21 | $240 +12% |
| JP Morgan | 63 % | +5.5 % | 27 | $200 -6% |
| TD Cowen | 39 % | +3.6 % | 18 | $193 -10% |
✅ Reasons to believe
- 5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Pays a dividend (2.4% yield) — regular income on top of potential upside.
- Reasonable valuation (P/E ~16) relative to its sector.
⚠️ Reasons to hesitate
- Even the most reliable firm on ACN, Wells Fargo (100% hit rate, 4 scored calls), only targets $210 (call made on October 2, 2026, maturing on October 2, 2027) (-2%) in its most recent call, and $248 (call made on June 4, 2026, maturing on June 4, 2027) (+16%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 17 ratings, 9 are neutral.
- Limited upside: the median target is only +0% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
The analyst consensus on ACN
Median target $213 (+0%) · 17 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Accenture now?
We won't decide for you. The facts: 47% of analysts rate it a buy, median target $213 (+0%), and Wells Fargo (most reliable on ACN, 100%) targets $210. Weigh that against valuation (P/E ~16) and volatility. This is not personalized advice.
Is it too late to invest in Accenture?
The stated upside is small: the median target ($213) sits just +0% from the price ($214) (most reliable on ACN: Wells Fargo, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Accenture still worth investing in?
It depends on the gap between the price ($214) and its estimated value: analysts target $213 on median (+0%), with 47% buys (most reliable on ACN: Wells Fargo, 100%). Cross-check with their real reliability on ACN and the cautions above. Information, not advice.
What's the main risk in buying ACN?
Even the most reliable firm on ACN, Wells Fargo (100% hit rate, 4 scored calls), only targets $210 (call made on October 2, 2026, maturing on October 2, 2027) (-2%) in its most recent call, and $248 (call made on June 4, 2026, maturing on June 4, 2027) (+16%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Accenture profile (consensus, analyst reliability, price target, performance).